IRIS
PIERONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.498
AS - Asia 3.023
EU - Europa 1.845
SA - Sud America 452
AF - Africa 179
Continente sconosciuto - Info sul continente non disponibili 165
OC - Oceania 7
Totale 9.169
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.412
SG - Singapore 1.019
CN - Cina 779
VN - Vietnam 518
IT - Italia 423
BR - Brasile 346
IE - Irlanda 299
SE - Svezia 237
HK - Hong Kong 229
DE - Germania 174
FI - Finlandia 152
TR - Turchia 114
ZA - Sudafrica 107
FR - Francia 104
NL - Olanda 97
GB - Regno Unito 69
IN - India 65
RU - Federazione Russa 65
AT - Austria 51
BD - Bangladesh 46
AR - Argentina 40
KR - Corea 40
CA - Canada 37
CI - Costa d'Avorio 28
IQ - Iraq 28
ES - Italia 27
ID - Indonesia 27
JP - Giappone 26
MX - Messico 26
BE - Belgio 25
PL - Polonia 25
PK - Pakistan 23
PH - Filippine 20
CZ - Repubblica Ceca 19
CO - Colombia 16
UA - Ucraina 15
SA - Arabia Saudita 14
VE - Venezuela 14
LT - Lituania 12
LU - Lussemburgo 12
EC - Ecuador 11
GH - Ghana 11
UZ - Uzbekistan 11
MA - Marocco 9
AE - Emirati Arabi Uniti 7
CL - Cile 7
EG - Egitto 7
MY - Malesia 7
TH - Thailandia 7
TW - Taiwan 7
BO - Bolivia 6
IL - Israele 6
PY - Paraguay 6
AL - Albania 5
AU - Australia 5
AZ - Azerbaigian 5
CR - Costa Rica 5
KZ - Kazakistan 5
TN - Tunisia 5
CH - Svizzera 4
DZ - Algeria 4
KG - Kirghizistan 4
LV - Lettonia 4
PA - Panama 4
PE - Perù 4
SN - Senegal 4
JM - Giamaica 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
CY - Cipro 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
IR - Iran 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
LK - Sri Lanka 1
Totale 8.995
Salva come PNG Salva come JPEG
Città #
Singapore 557
Ashburn 479
Chandler 339
San Jose 339
Dublin 296
Dallas 259
Hong Kong 212
Santa Clara 212
Beijing 166
Ho Chi Minh City 158
Ann Arbor 146
Hanoi 118
Parma 117
Council Bluffs 114
Johannesburg 99
Boardman 97
Los Angeles 91
Shanghai 76
Izmir 73
Dearborn 72
Munich 63
Lauterbourg 62
Nanjing 62
New York 60
Hefei 59
Princeton 57
Helsinki 55
Columbus 46
Wilmington 43
Bremen 40
Vienna 37
Chicago 35
São Paulo 33
Moscow 32
Buffalo 30
Turku 30
Abidjan 28
The Dalles 28
Hillsboro 27
Bologna 26
Frankfurt am Main 24
Guangzhou 24
Milan 24
Seoul 23
Haiphong 22
London 22
Kocaeli 21
Warsaw 21
Da Nang 20
Atlanta 19
Jakarta 19
San Mateo 18
Seattle 18
Shenyang 18
Tokyo 18
Brooklyn 17
Brussels 17
Nanchang 17
Falls Church 16
Hebei 16
Houston 16
Chennai 15
Changsha 14
Brasília 13
Jinan 13
Orem 13
Brno 12
Jiaxing 12
Norwalk 12
Toronto 11
Amsterdam 10
Baghdad 10
Curitiba 10
Kyiv 10
Montreal 10
Nuremberg 10
Phoenix 10
Accra 9
Istanbul 9
Denver 8
Des Moines 8
Fremont 8
Luxembourg 8
Porto Alegre 8
Rio de Janeiro 8
Rome 8
Verona 8
Bengaluru 7
Cairo 7
Caracas 7
Florence 7
Manchester 7
Modena 7
Stockholm 7
Tashkent 7
Tianjin 7
Washington 7
Ahmedabad 6
Belo Horizonte 6
Boston 6
Totale 5.638
Salva come PNG Salva come JPEG
Nome #
Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants 267
Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant 219
Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties 207
Refining the structure−activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms 199
A competitive o‐acetylserine sulfhydrylase inhibitor modulates the formation of cysteine synthase complex 195
Nuovi composti antimicrobici 195
Inhibitors of O-Acetylserine Sulfhydrylase with a Cyclopropane-Carboxylic Acid Scaffold Are Effective Colistin Adjuvants in Gram Negative Bacteria 192
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 184
Rational Design, Synthesis and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella Typhimurium O-Acetylserine Sulfhydrylase 182
Chemical Probes to Investigate Central Nervous System Disorders: Design, Synthesis and Mechanism of Action of a Potent Human Serine Racemase Inhibitor 181
Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets 178
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics 177
Inhibition of Nonessential Bacterial Targets: Discovery of a Novel Serine O-Acetyltransferase Inhibitor 177
Inhibitors of the sulfur assimilation pathway in bacterial pathogens as enhancers of antibiotic therapy 168
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry 168
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents 167
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 164
Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR 163
Antituberculosis agents: Beyond medicinal chemistry rules 159
Towards the sustainable discovery and development of new antibiotics 159
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 159
Blocking cysteine biosynthesis in Salmonella typhimurium: the moonlighting enzyme CysK as a potential antibiotic target 156
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 149
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery 145
Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target 144
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A 144
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation 144
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 143
Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics 143
Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design 142
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin 141
Quorum sensing inhibitors (QSIs): a patent review (2019–2023) 140
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 134
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria 133
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 132
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 132
In vitro digestion of zingiber officinale extract and evaluation of stability as a first step to determine its bioaccesibility 131
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 126
Challenging the drug-likeness dogma for new drug discovery in Tuberculosis 124
Biochemical characterization of Aspergillus fumigatus AroH, a putative aromatic amino acid aminotransferase 124
Sodium Hyaluronate Microparticles for Pulmonary Delivery of Anti-mycobacterial Drugs 123
Design, Synthesis and Investigation onthe Structure–Activity Relationships of N-Substituted 2-Aminothiazole Derivatives as Antitubercular Agents 120
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 120
Derivatives of 3-isoxazolecarboxylic acid esters - a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis 119
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy 118
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 114
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation article 112
Pheochromocytoma-induced cardiogenic shock: A multicentre analysis of clinical profiles, management and outcomes 110
From 6-aminoquinolone antibacterials to 6-amino-7- thiopyranopyridinylquinolone ethyl esters as inhibitors of staphylococcus aureus multidrug efflux pumps 98
Preliminary structure - Activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains 96
Structural analogs of huperzine A improve survival in guinea pigs exposed to soman 95
Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1) 94
Benzotriazole derivatives as alternate O-acetylserine sulfhydrylase substrates to impair cysteine biosynthesis in Gram-negative bacteria 92
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway 92
NOC chemistry for tuberculosis - Further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives 89
Indoleamides are active against drug-resistant mycobacterium tuberculosis 86
Synthesis of 7-desmethyl analogs of (+)- and (-)-huperzine A 85
Searching for innovative quinolone-like scaffolds: Synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 83
Pyrroloquinolone-Based Compounds as a Novel Antimycobacterial Chemotype 81
Synthesis and Structure-Activity Relationships of Lansine Analogues as Antileishmanial Agents 79
Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania 76
Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB 74
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. A potent and selective series for further drug development 74
Spectinamides: A challenge, a proof, and a suggestion 73
Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains 73
In pursuit of natural product leads: Synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4- carboxylic acid (A-33853) and its analogues: Discovery of N-(2-benzoxazol-2- ylphenyl)benzamides as novel antileishmanial chemotypes 73
From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters 73
Mutation of Rv2887, a marR-Like gene, confers mycobacterium tuberculosis resistance to an imidazopyridine-based agent 70
Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes 62
Gaining insights into MmpL3: combining structural and computational approaches to unlock transport and inhibitor-binding mechanisms 28
Totale 9.169
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.357
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022364 0 28 25 25 10 38 20 26 35 22 21 114
2022/20231.261 118 138 79 100 146 149 7 65 374 15 41 29
2023/2024507 24 40 17 28 49 72 48 44 26 28 40 91
2024/20251.751 64 90 144 95 151 221 109 69 155 163 195 295
2025/20264.080 414 357 554 359 563 225 448 157 470 291 154 88
2026/2027179 76 103 0 0 0 0 0 0 0 0 0 0
Totale 9.169